VFA
AMAG

Virtus Fund Advisers’s AMAG Pharmaceuticals AMAG Stock Holding History

Virtus Fund Advisers’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,870
Closed -$39K – 2203
2014
Q2 		$39K Buy
+1,870
New +$34.6K ﹤0.01% 2036

Other funds holding AMAG

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Virtus Fund Advisers's AMAG Position: Q3 2014 in Review

Virtus Fund Advisers sold out of AMAG Pharmaceuticals (AMAG) in Q3 2014, closing a stake of 1,870 shares — an estimated $39K sold.

Virtus Fund Advisers first reported a position in AMAG in Q2 2014 and held it in 1 quarter. The position peaked at $39K in Q2 2014. 113 funds tracked by Wall St. Rank hold AMAG as of Q3 2014.

  • Virtus Fund Advisers reported no remaining AMAG Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 1,870 AMAG Pharmaceuticals shares in Q3 2014, an estimated $39K.
  • Virtus Fund Advisers first reported a position in AMAG Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's AMAG Pharmaceuticals position peaked at $39K in Q2 2014.
  • 113 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.